Repligen Corporation
(RGEN - NASDAQ)
117,92 USD
📋 Profilo Aziendale

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally.

|